Evoke Pharma Inc. (EVOK) |
|
0.88 0.027 (3.12%)
|
08-16 15:59 |
|
Open: |
0.9301 |
Pre. Close: |
0.8534 |
|
High:
|
0.939 |
Low:
|
0.8312 |
|
Volume:
|
394,448 |
Market Cap:
|
21M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.941 - 0.944 |
0.944 - 0.949 |
|
Low:
|
0.821 - 0.825 |
0.825 - 0.829 |
|
Close:
|
0.873 - 0.879 |
0.879 - 0.886 |
|
Technical analysis |
as of: 2019-08-16 4:48:00 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 1.36 One year: 1.62 |
| Support: |
Support1: 0.80 Support2: 0.67 |
| Resistance: |
Resistance1: 1.17 Resistance2: 1.39 |
| Pivot: |
0.91  |
| Moving Average: |
MA(5): 0.87 MA(20): 0.97
MA(100): 0.79 MA(250): 1.87 |
| MACD: |
MACD(12,26): -0.01 Signal(9): 0.02 |
| Stochastic oscillator: |
%K(14,3): 20.74 %D(3): 17.62 |
| RSI: |
RSI(14): 47.54 |
| 52-week: |
High: 3.40 Low: 0.50 Change(%): -63.9 |
| Average Vol(K): |
3-Month: 81005 10-Days: 34040 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.EVOK has closed above bottom band by 34.3%. Bollinger Bands are 45% narrower than normal. The narrow width of the bands suggests low volatility as compared to EVOK's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 08 May 2019 17:55:08 Z
Evoke Pharma (EVOK) to Post Q1 Earnings: What's in Store?
Mon, 15 Apr 2019 18:08:56 Z
Dr. Reddy's (RDY) Inks Deal to Acquire Portfolio of 42 ANDAs
Tue, 02 Apr 2019 20:38:28 Z
Health Care Sector Update for 04/02/2019: IMAC,RUBY,ADMA,EVOK
Tue, 02 Apr 2019 18:38:24 Z
Health Care Sector Update for 04/02/2019: RUBY,ADMA,EVOK
Tue, 02 Apr 2019 15:38:31 Z
Mid-Morning Market Update: Markets Edge Lower; Walgreens Misses Q2 Views
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Specialty Generic |
| Shares Out. (M) |
17.43 |
| Shares Float (M) |
20.20 |
|
% Held by Insiders
|
5.68 |
|
% Held by Institutions
|
30.35 |
|
Shares Short (K)
|
701 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
-0.445 |
|
EPS Est. Current Year
|
-0.820 |
|
EPS Est. Next Year
|
-0.170 |
|
EPS Est. Next Quarter
|
-0.190 |
|
Forward EPS
|
-0.160 |
|
Book Value (p.s.)
|
0.170 |
|
PEG Ratio
|
-0.05 |
|
Profit Margin
|
|
|
Operating Margin
|
|
|
Return on Assets (ttm)
|
-95.1 |
|
Return on Equity (ttm)
|
-202.3 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-6.09 |
|
Levered Free Cash Flow (M)
|
-3.27 |
Stock Valuations |
|
P/E
|
-1.98 |
|
P/E Growth Ratio
|
0.02 |
|
P/BV
|
5.18 |
|
P/S
|
|
|
P/CF
|
-2.52 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
